Skip to main content

Advertisement

Log in

Transient and persistent conduction abnormalities following transcatheter aortic valve replacement with the Edwards-Sapien prosthesis: a comparison between antegrade vs. retrograde approaches

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Background

Electrocardiographic conduction abnormalities following transcatheter aortic valve replacement (TAVR) with the Edwards-Sapien valve (ESV) are not uncommon and may be transient. We sought to examine the clinical time-course of conduction abnormalities after TAVR with ESV and determine risk factors for persistent abnormalities.

Methods

In this single-center prospective study, 116 consecutive patients underwent implantation of the ESV after approval by the Food and Drug Administration (FDA). Demographic, clinical, and intra-procedural variables were collected in a registry, including ECGs before, immediately after, and at discharge from hospital. Conduction abnormalities were analyzed including PR interval lengthening, QRS widening, left bundle branch block (LBBB), and high-grade AV block.

Results

There were 92 patients included in the analysis. A total of 41 new conduction abnormalities were observed in 31 (34 %) patients: 7 new PR prolongation, 14 QRS widening, 14 new LBBB, and 5 high-grade AV block requiring permanent pacemaker. Of the 41 new CAs, 11 (27 %) were transient; of the transient abnormalities, 9 (82 %) resolved within 24 h of the index procedure. Chronic kidney disease was a risk factor for the development of a persistent abnormality and for need for PPM. Antegrade approach was associated with the development of persistent LBBB and persistent QRS widening.

Conclusions

A significant proportion of conduction abnormalities after ESV implantation improved prior to discharge from the hospital, usually within 24 h. CKD is associated with persistence of abnormalities and with need for PPM. Antegrade approach increases risk for new intraventricular conduction delays, including LBBB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

ECG:

Electrocardiogram

TAVR:

Transcatheter aortic valve replacement

PPM:

Permanent pacemaker

LBBB:

Left bundle branch block

LAFB:

Left anterior fascicular block

POD:

Post-operative day

References

  1. Laynez A, Ben-Dor I, Barbash IM, et al. Frequency of conduction disturbances after Edwards SAPIEN percutaneous valve implantation. Am J Cardiol. 2012;110:1164–8.

    Article  PubMed  Google Scholar 

  2. Roten L, Wenaweser P, Delacretaz E, et al. Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol. 2010;106:1473–80.

    Article  PubMed  Google Scholar 

  3. Gutierrez M, Rodes-Cabau J, Bagur R, et al. Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation. Am Heart J. 2009;158:302–8.

    Article  PubMed  Google Scholar 

  4. Aktug O, Dohmen G, Brehmer K, et al. Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation. Int J Cardiol. 2012;160:26–30.

    Article  PubMed  Google Scholar 

  5. Houthuizen P, Van Garsse LA, Poels TT, et al. Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation. 2012;126:720–8.

    Article  PubMed  Google Scholar 

  6. Sinhal A, Altwegg L, Pasupati S, et al. Atrioventricular block after transcatheter balloon expandable aortic valve implantation. J Am Coll Cardiol Intv. 2008;1:305–9.

    Article  Google Scholar 

  7. Steinberg BA, Harrison JK, Frazier-Mills C, Hughes GC, Piccini JP. Cardiac conduction system disease after transcatheter aortic valve replacement. Am Heart J. 2012;164:664–71.

    Article  PubMed  Google Scholar 

  8. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.

    Article  CAS  PubMed  Google Scholar 

  9. Erkapic D, De Rosa S, Kelava A, Lehmann R, Fichtlscherer S, Hohnloser SH. Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol. 2012;23:391–7.

    Article  PubMed  Google Scholar 

  10. Godino C, Maisano F, Montorfano M, et al. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience. J Am Coll Cardiol Intv. 2010;3:1110–21.

    Article  Google Scholar 

  11. Bleiziffer S, Ruge H, Horer J, et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. J Am Coll Cardiol Intv. 2010;3:524–30.

    Article  Google Scholar 

  12. Godin M, Eltchaninoff H, Furuta A, et al. Frequency of conduction disturbances after transcatheter implantation of an Edwards Sapien aortic valve prosthesis. Am J Cardiol. 2010;106:707–12.

    Article  PubMed  Google Scholar 

  13. Roten L, Stortecky S, Scarcia F, et al. Atrioventricular conduction after transcatheter aortic valve implantation and surgical aortic valve replacement. J Cardiovasc Electrophysiol. 2012;23:1115–22.

    Article  PubMed  Google Scholar 

  14. Piazza N, de Jaegere P, Schultz C, Becker AE, Serruys PW, Anderson RH. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv. 2008;1:74–81.

    Article  PubMed  Google Scholar 

  15. Rubin JM, Avanzas P, del Valle R, et al. Atrioventricular conduction disturbance characterization in transcatheter aortic valve implantation with the CoreValve prosthesis. Circ Cardiovasc Interv. 2011;4:280–6.

    Article  PubMed  Google Scholar 

  16. Urena M, Mok M, Serra V, et al. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol. 2012;60:1743–52.

    Article  PubMed  Google Scholar 

  17. Haworth P, Behan M, Khawaja M, et al. Predictors for permanent pacing after transcatheter aortic valve implantation. Catheter Cardiovasc Interv: Off J Soc Cardiac Angiography Interv. 2010;76:751–6.

    Article  Google Scholar 

  18. Piazza N, Onuma Y, Jesserun E, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. J Am Coll Cardiol Intv. 2008;1:310–6.

    Article  Google Scholar 

  19. Houthuizen P, van der Boon RM, Urena M, et al. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation. EuroIntervention: J EuroPCR Collab Work Group Interv Cardiol Eur Soc Cardiol. 2014;9:1142–50.

    Article  Google Scholar 

  20. Nazif TM, Williams MR, Hahn RT, et al. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J. 2014;35:1599–607.

    Article  PubMed  Google Scholar 

  21. Nuis RJ, Van Mieghem NM, Schultz CJ, et al. Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve System in patients with aortic stenosis. Eur Heart J. 2011;32:2067–74.

    Article  PubMed  Google Scholar 

  22. Lardizabal JA, O’Neill BP, Desai HV, et al. The transaortic approach for transcatheter aortic valve replacement: initial clinical experience in the United States. J Am Coll Cardiol. 2013;61:2341–5.

    Article  PubMed  Google Scholar 

  23. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation. 2006;114:591–6.

    Article  PubMed  Google Scholar 

  24. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755–63.

    Article  PubMed  Google Scholar 

  25. Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation. 2007;116:I240–5.

    Article  PubMed  Google Scholar 

  26. Willems JL, de Medina EO R, Bernard R, et al. Criteria for intraventricular conduction disturbances and pre-excitation. World Health Organizational/International Society and Federation for Cardiology Task Force Ad Hoc. J Am Coll Cardiol. 1985;5:1261–75.

    Article  CAS  PubMed  Google Scholar 

  27. Cohen MG, Singh V, Martinez CA, et al. Transseptal antegrade transcatheter aortic valve replacement for patients with no other access approach—a contemporary experience. Catheter Cardiovasc Interv: Off J Soc Cardiac Angiography Interv. 2013;82:987–93.

    Article  Google Scholar 

  28. Ye J, Cheung A, Lichtenstein SV, et al. Transapical transcatheter aortic valve implantation: follow-up to 3 years. J Thorac Cardiovasc Surg. 2010;139:1107–13. 1113 e1.

    Article  PubMed  Google Scholar 

  29. Walther T, Schuler G, Borger MA, et al. Transapical aortic valve implantation in 100 consecutive patients: comparison to propensity-matched conventional aortic valve replacement. Eur Heart J. 2010;31:1398–403.

    Article  PubMed  Google Scholar 

  30. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol: JASN. 2005;16:489–95.

    Article  PubMed  Google Scholar 

  31. Shamseddin MK, Parfrey PS. Mechanisms of the cardiorenal syndromes. Nat Rev Nephrol. 2009;5:641–9.

    Article  PubMed  Google Scholar 

  32. Ravani P, Tripepi G, Malberti F, Testa S, Mallamaci F, Zoccali C. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. J Am Soc Nephrol: JASN. 2005;16:2449–55.

    Article  CAS  PubMed  Google Scholar 

  33. Tanawuttiwat T, O’Neill BP, Cohen MG, et al. New-onset atrial fibrillation after aortic valve replacement: comparison of transfemoral, transapical, transaortic, and surgical approaches. J Am Coll Cardiol. 2014;63:1510–9.

    Article  PubMed  Google Scholar 

  34. Damluji AA, Al-Damluji MS, Marzouka GR, et al. New-onset versus prior history of atrial fibrillation: outcomes from the AFFIRM trial. Am Heart J. 2015;170:156–63. e1.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Solomon J. Sager.

Ethics declarations

Funding

None.

Disclosures

All other authors have no conflict of interest.

Additional information

Solomon J. Sager and Abdulla A. Damluji contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sager, S.J., Damluji, A.A., Cohen, J.A. et al. Transient and persistent conduction abnormalities following transcatheter aortic valve replacement with the Edwards-Sapien prosthesis: a comparison between antegrade vs. retrograde approaches. J Interv Card Electrophysiol 47, 143–151 (2016). https://doi.org/10.1007/s10840-016-0145-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-016-0145-2

Keywords

Navigation